Isabelle Riviere

Director/Miembro de la Junta en Centre For Commercialization of Cancer Immunotherapy .

Health Technology

Perfil

Isabelle Riviere is the founder of Juno Therapeutics, Inc. which was founded in 2013.
Currently, she holds the position of Director at the Centre For Commercialization of Cancer Immunotherapy.

Cargos activos de Isabelle Riviere

Empresas	Cargo	Inicio
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.	Director/Miembro de la Junta	-

Todos los cargos activos de Isabelle Riviere

Antiguos cargos conocidos de Isabelle Riviere.

Empresas	Cargo	Fin
JUNO THERAPEUTICS INC	Fundador	-

Ver el detalle de la experiencia de Isabelle Riviere.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Isabelle Riviere.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA.	Health Technology
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.